After years of patent protection, biosimilars for Humira are set to enter the US market in 2023. The arrival of these drugs has been widely anticipated throughout the healthcare industry. Yet, their ...
For the first time, pharmacists in the US will be able to substitute a cheaper biosimilar version when they receive a prescription for AbbVie’s high-concentration formulation of Humira, without the ...
The ShinyHunters extortion gang stole personal information belonging to over 119,000 people after hacking the Vimeo online video platform in April, according to data breach notification service Have I ...
Hosted on MSN
AbbVie lifts guidance despite slump in Humira sales
AbbVie (NYSE:ABBV) on Thursday recorded better-than-expected financials for Q2 2025 and raised its full-year earnings outlook as the company’s newer immunology drugs offset a sharp sales decline for ...
Antagonists of tumor necrosis factor (TNF) have revolutionized the treatment of selected inflammatory diseases. In rheumatology, this has been most notable for ankylosing spondylitis, psoriatic ...
Vimeo, the second-largest video hosting, sharing, and streaming service, has confirmed a data breach that affected approximately 119,000 users and customers. With a market share of over 18%, Vimeo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results